ARRANGED AS TO MOST RECENT DEVELOPMENTS:
Contrasting Effects of Low Dose IL-2 on Vaccine Boosted Simian Immunodeficiency Virus (SIV) Specific CD4+ and CD8+ T Cells in Macaques Chronically Infected with SIVmac251
Journal of Immunology, February 15, 2005
The Quantal Theory of How the Immune System Discriminates Between "Self and Non-Self"
http://www.medimmunol.com/content/pdf/1476-9433-3-3.pdf
Numedx article: “New paradigms in HIV therapy: Boosting_HIV_ Immunity”
Numedex_NEW PARADIGMS_IN_HIV_THERAPY_final.pdf
Commentary: The HIV vaccine Saga
http://www.medimmunol.com/content/2/1/1
Commentary: Optimal Clinical Trial Design for Immune-Based Therapies in Chronic Viral Infections
http://www.medimmunol.com/content/1/1/4
A New Journal, Medical Immunology, is now On-Line
Hepatitis C Virus Infection: Why it is Such a Growing Problem
Notes from Kendall A. Smith, August 2002
Report from Barcelona-IV International AIDS Congress
Notes from Kendall A. Smith, July, 2002
Towards a Cure of Chronic HIV Infection: Can HIV Vaccines and Interleukin 2 Help Promote Immunity to HIV?
Notes from Kendall A. Smith, June 12, 2002
Frequently Asked Questions Concerning Immunotherapy Clinical Trials
ALVAC / IL2 Clinical Trial Frequently Asked Questions
Highlights from the 8th Conference on Retroviruses & Opportunistic Infections February 4-8, 2001
What is Therapeutic Vaccination?
Essay on Therapeutic Immunization: Principles & Practice-January 24, 2001
Designing Clinical Trials for Immune-Based Therapies
Commentary for The AIDS Reader-in press, January, 2001
Current IL2 Clinical Trials Enrolling Subjects
Cornell Trial of Immune-Based Therapies: Low Dose Daily IL2 & Canarypox HIV Vaccine
Protocol (PDF File)
Consent
Form (PDF File)
Essay on IL2 Toxicities
December 24, 2000, Follow-up of Essay on Low Dose IL2 Therapy
Summary of Workshop on Immune Based Therapies & HIV Disease-
The Forum for Collaborative HIV Research, December 7-8, 2000
Low Dose Daily IL2 Therapy vs. High Dose Intermittent IL2 Therapy
Essay by Kendall A. Smith, January 12, 2001, edited from December 24, 2000
8th Annual Conference on Retroviruses & Opportunistic Infections, Chicago, ILL, February 4-8, 2001
Abstract # B75e-In Vivo Assessment of Antiviral Reactivity in Chronic HIV Infection (PDF file)
Weill Cornell Studies Reveal Accelerated Improvement of Immune System & Antiviral Reactivity in Chronic HIV Infection: Low Daily Doses of Interleukin 2 May Hold Key to Management of HIV Infection
Cornell Press Release, November 13, 2000
New Results in Vaccine + IL2 Studies in Macaques
Report in Nature, October 20, 2000
Therapeutic Vaccination of Macaques Treated with HAART
Immunologic Control of HIV Infection in Acute Infection
IL-2 Low Dose and Treatment Interruption: Interview with Kendall A. Smith, M.D.
Weill Cornell Researchers Develop New Treatment for HIV-Positive Patients